Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

BLCO

$17.11+1.00%website ↗⬇ financials (.py)

Bausch & Lomb Corp

Market Cap
$6.1B
Live price × shares (2026-09-16)
Sector
Health Care
Industry
Health Care
Beta (raw)
0.54
52mo monthly vs SPY
P/E (TTM)
N/M
Price / TTM net income
P/S (TTM)
1.1
Price / TTM revenue
P/B
1.0
Price / stockholders equity
EV/EBITDA
14.7
TTM
Price Chart
Loading…

Signals

Insider Velocity
24.9x
selling
Congress
—
recent trades
Short Volume
64%
W/W +9.6pp

Market & Alt Data

News
15
recent articles
Activist
—
none active
Analyst Consensus
Buy
18 analysts
Velocity Score
24.85x
Sell Rate (90d)
793.99/mo
Sell Baseline
0.00/mo
Unique Sellers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-08-102026-08-12Munsch FrederickSVP, Controller and CAOSale52.9K$16.78$888K45.8KView
2026-08-072026-08-10VON ESCHENBACH ANDREW C.DirectorSale6,059$16.58$100K63.7KView
2026-08-062026-08-10VON ESCHENBACH ANDREW C.DirectorSale12.5K$16.50$206K69.8KView
2026-03-062026-03-10Bailey A Robert DEVP & Chief Legal OfficerPurchase14.6K$17.15$250K231.9KView
2026-03-062026-03-10Eldessouky SamEVP and CFOPurchase4,000$17.13$69K403.1KView
1–5 of 12
1 / 3

Reporting Insiders

  • Frederick Munsch
    SVP, Controller and CAO
    1 transaction · last 2026-08-10
  • Eschenbach Andrew C. Von
    Director
    2 transactions · last 2026-08-07
  • A. Robert D. Bailey
    EVP & Chief Legal Officer
    1 transaction · last 2026-03-06
  • Sam Eldessouky
    EVP and CFO
    1 transaction · last 2026-03-06
  • Brent L. Saunders
    Director & CEO and Chairman of the Board
    1 transaction · last 2026-03-06
  • Thomas W. Ross Sr.
    Director
    1 transaction · last 2026-03-03
  • Eduardo Alfonso
    Director
    1 transaction · last 2026-03-02

Recent News

Bausch + Lomb will give a business update in a live webcast at 8 a.m. Oct. 28
Stock Titan · 2026-10-05
Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28
Yahoo Finance · 2026-10-05
BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure
Stocktwits · 2026-10-02
Bausch + Lomb (BLCO) Stock Price, News & Analysis
MarketBeat · 2026-10-02
Bausch + Lomb (BLCO) Earnings Date and Reports 2026
MarketBeat · 2026-10-02
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
Yahoo · 2026-10-01
Responsive Playbooks and the BLCO Inflection
Stock Traders Daily · 2026-09-30
‘Crisis of Its Own Creation’: Activist JANA Blasts Cooper, Demands CEO Search
Benzinga · 2026-09-18
3 Small-Cap Stocks That Concern Us
Yahoo · 2026-09-17
Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026
Yahoo · 2026-09-16
Bausch + Lomb Receives FDA Warning Letter Over Sterile Drug Manufacturing At Tampa Plant, Citing Inadequate Aseptic Controls And Persistent Microbial Contamination; Products Deemed Adulterated
Benzinga · 2026-09-15
Needham Reiterates Hold on Bausch & Lombto Hold
Benzinga · 2026-09-15
Tracking Carl Icahn's 13F Report - Q2 2026 Update
SeekingAlpha · 2026-09-14
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser
Yahoo · 2026-09-14
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
Yahoo · 2026-09-11

Informational purposes only, not investment advice.

Bausch & Lomb Corp (BLCO)

tormere.com/research/BLCO · generated 2026-10-05

$17.11
+1.00%
General Information
Price$17.11
Change+1.00%
Market Cap$6.1B
SectorHealth Care
IndustryHealth Care
ExchangeNYSE
Beta (raw, 52mo vs SPY)0.54
Signals
Insider Velocity24.9x selling
Congress Trades—
  • Eschenbach Andrew C. Von
    Director
    1 transaction · last 2026-02-27
  • Steven H. Collis
    Director
    1 transaction · last 2026-02-23
  • Russel C. Robertson
    Director
    1 transaction · last 2026-02-20
  • Karen Ling
    Director
    1 transaction · last 2026-02-19
    • Short Volume
    64% of daily vol
    Conviction Score16/100
    Analyst ConsensusSB 3 · B 7 · H 7 · S 1 · SS 0
    Price Chart (1 Year)
    2025-10-062026-10-02$18.60$14.32
    Recent Insider Activity (Form 4) — Last 5
    DateInsiderTypeSharesValue
    2026-08-10Munsch FrederickS52,900$887,662
    2026-08-07VON ESCHENBACH ANDREW C.S6,059$100,458.22
    2026-08-06VON ESCHENBACH ANDREW C.S12,500$206,250
    2026-03-06Bailey A Robert DP14,600$250,331.6
    2026-03-06Eldessouky SamP4,000$68,520
    Recent News
    • Bausch + Lomb will give a business update in a live webcast at 8 a.m. Oct. 28 — Stock Titan · 2026-10-05
    • Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28 — Yahoo Finance · 2026-10-05
    • BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure — Stocktwits · 2026-10-02
    • Bausch + Lomb (BLCO) Stock Price, News & Analysis — MarketBeat · 2026-10-02
    • Bausch + Lomb (BLCO) Earnings Date and Reports 2026 — MarketBeat · 2026-10-02

    Tormere — informational purposes only, not investment advice.

    Factor Profile

    Pro
    Pro feature

    Fama-French factor analysis is available on the Pro plan.

    Upgrade to Pro →